Mediterranean diet for ulcerative colitis
Part of Digestive system clinical trials.
This study tests whether a modified Mediterranean diet can help people with mild to moderate ulcerative colitis. It may reduce inflammation and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have ulcerative colitis confirmed by a scope test within the last 4 months.
- Your disease is mild to moderate, based on symptoms and tests like calprotectin or ultrasound.
- You are on a stable dose of your current UC medications, or you are on steroids that can be reduced.
- You are not currently using tube feeding, antibiotics, or have certain other conditions like diabetes or Crohn's disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a specially designed supplement that aims to restore healthy gut bacteria in people with mild-to-moderate ulcerative colitis. The goal is to reduce inflammation and improve symptoms like rectal bleeding and bowel urgency.
This study tests whether a combination of fecal transplant (transferring healthy stool into your gut) and dietary changes can help control inflammation in people recently diagnosed with active ulcerative colitis. It may offer a new treatment option before starting stronger medications.
This study uses breath tests to see how a special diet changes gases in your gut that might affect ulcerative colitis. It aims to find out if these changes can help manage your condition.
This study tests a new way to monitor ulcerative colitis using stool tests and colonoscopy to detect early signs of cancer. It may help doctors manage long-term ulcerative colitis more safely.
This study tests whether taking vitamin D3 by mouth can reduce inflammation in people with moderate ulcerative colitis and low vitamin D levels. It may help if you have a confirmed diagnosis and are between 20–40 years old.
This trial tests an oral study drug called Hemay005 for people with moderate to severe ulcerative colitis (UC) who have not responded well to other treatments. If you join, you will receive either the study drug or a placebo (inactive pill) to see if it helps reduce symptoms and heal the gut lining.
Hear when a new Ulcerative Colitis (UC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.